Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has demonstrated remarkable effects on weight management in recent clinical trials. In a landmark 2023 study, participants taking semaglutide lost an average of 15% of their starting body weight over 68 weeks, significantly more than those on placebo. PlexusDx delivers compounded semaglutide from licensed 503A pharmacies to all 50 states without requiring insurance or membership fees.

How Semaglutide Works for Weight Loss

Semaglutide functions by mimicking glucagon-like peptide-1 (GLP-1), a hormone that regulates appetite and blood sugar levels in your body. When semaglutide binds to GLP-1 receptors in the brain, it sends signals of fullness that reduce hunger cravings and decrease the amount of food you want to eat at each meal. This mechanism operates differently from stimulant-based diet medications, making it suitable for long-term use without the crash-and-burn cycle of older weight loss drugs.

The medication also slows gastric emptying, meaning food moves through your stomach more gradually, promoting sustained satiety between meals. Additionally, semaglutide improves how your body handles glucose, reducing energy crashes that often trigger overeating. These combined effects address both the psychological and physiological drivers of weight gain, which is why patients often report feeling naturally less interested in food rather than forcing restriction.

Clinical Evidence: Real Weight Loss Results

The STEP trials, the largest phase 3 clinical studies for semaglutide in weight management, tracked over 4,500 participants across multiple sites. Patients receiving semaglutide 2.4 mg weekly achieved an average weight loss of 14.9% of body weight at one-year follow-up, while the placebo group lost only 2.4%. When combined with structured lifestyle support including diet and exercise counseling, semaglutide users in some cohorts lost up to 22% of their starting weight.

Weight loss typically becomes noticeable after 4-8 weeks of consistent treatment, with the most significant changes occurring between months 3 and 6. Long-term studies show that people who maintain semaglutide therapy continue holding onto their weight loss, whereas many who stop the medication gradually regain weight over subsequent months. This pattern suggests semaglutide addresses underlying metabolic and appetite regulation rather than forcing temporary calorie restriction.

Individual Factors That Influence Your Results

Your genetic makeup plays a measurable role in how effectively semaglutide works for your specific body. Variations in the GLP1R gene (such as rs6923761) and the GIPR gene (rs1800437) influence how sensitive your body's receptors are to the medication, potentially affecting both efficacy and the dose you'll need. PlexusDx's Precision Peptide Genetic Test examines these and 47 other genetic pathways to predict your likely response before committing to long-term treatment.

Beyond genetics, your starting weight, age, insulin resistance level, and adherence to lifestyle modifications all shape outcomes. People with more significant initial obesity often see larger absolute weight losses, while those closer to their goal weight may lose more slowly but still achieve meaningful health improvements. Consistent physical activity and balanced nutrition amplify semaglutide's effects, transforming medication into a tool that works with rather than replaces healthy habits.

PlexusDx Semaglutide Options and Affordability

PlexusDx provides compounded semaglutide injections through licensed 503A pharmacies at a flat monthly price starting at $149, regardless of your dose strength. Your dose may need to go up as your body adapts, but your price won't—a transparent pricing model that removes the financial guessing game of dose-dependent costs. All medications ship to your home in all 50 states without requiring insurance coverage or paying membership fees, making treatment accessible to a broader population.

For patients preferring oral administration, PlexusDx offers oral semaglutide starting at $249 per month. Treatment becomes HSA and FSA eligible, allowing you to use pre-tax healthcare funds to cover your medication costs. After your first month of treatment, you can add the Precision Peptide Genetic Test for $99 to gain detailed insights into your peptide-pathway genetics and optimize your protocol beyond standard dosing.

What to Expect During Your First Months

Most patients begin with a lower starting dose that increases gradually every 4 weeks until reaching an effective maintenance level, typically 2.4 mg weekly for weight loss. This titration approach allows your body to adjust to the medication and helps minimize side effects such as nausea, which is most common during the first 2-4 weeks. The adjustment period is temporary; many patients report that early nausea resolves within days to weeks as their body acclimates.

Sustained weight loss momentum often peaks around month 4-6 of treatment, after which the rate may slow but continues steadily over subsequent months. Drinking adequate water, eating smaller portions of protein-rich foods, and limiting high-fat meals can enhance tolerance and maximize results. PlexusDx's treatment model includes ongoing support to help you navigate dosing adjustments and lifestyle integration, ensuring you stay on track toward your health goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I lose on semaglutide?

Clinical trials show average weight loss of 14-15% of body weight within one year, with some patients losing up to 22% when combining medication with consistent lifestyle changes. Your individual results depend on genetics, starting weight, dose tolerance, and adherence to diet and exercise. PlexusDx can assess your genetic peptide-pathway profile to help predict your likely response.

How quickly does semaglutide start working?

Most patients notice reduced hunger and early appetite changes within 2-4 weeks, though measurable weight loss typically becomes visible after 4-8 weeks of treatment. Maximum effectiveness is usually reached around month 3-6 as your body fully adjusts to the medication and you build sustainable eating and activity habits.

Is semaglutide safe for long-term use?

Semaglutide has been used safely for type 2 diabetes management for over a decade, with weight-loss studies tracking safety over multiple years. Common side effects are gastrointestinal (nausea, vomiting) and typically mild and temporary, resolving within weeks. However, it's not appropriate for everyone—discuss your full medical history, including family history of thyroid cancer or pancreatitis, with your healthcare provider.

What's the cost of semaglutide at PlexusDx?

PlexusDx compounded semaglutide injections start at $149 per month with no flat per-compound pricing increases, while oral semaglutide begins at $249 per month. Both options are available in all 50 states without insurance requirements or membership fees and are HSA/FSA eligible. Add the Precision Peptide Genetic Test after your first month for $99.

What role do genes play in how well semaglutide works?

Genetic variants in your GLP1R gene (rs6923761) and GIPR gene (rs1800437) directly influence how your body responds to semaglutide, affecting both weight loss magnitude and optimal dosing. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides to reveal your personalized peptide genetics, helping predict treatment efficacy and guide customized protocols.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves